Zymetech

Zymetech is an Icelandic biotechnology company specializing in the development and manufacture of therapeutic enzymes derived from North Atlantic cod. The company's proprietary Penzyme technology utilizes cold-adapted trypsin to create barriers against viruses and promote skin healing. Zymetech was acquired by the Swedish life sciences company Enzymatica in 2016, integrating its enzyme expertise into the production of the ColdZyme mouth spray. Its research focuses on the application of marine enzymes in pharmaceuticals, medical devices, and cosmetics. The company continues to operate as a key research and manufacturing hub within the Enzymatica group, focusing on marine-derived biocatalysts.